Genentech

XOLAIR

Manufacturer:

Genentech

Xolair HCPCS:

J2357

HCPCS Code Descriptor:

Injection, omalizumab, 5 mg

Category:

J Code

Xolair NDCs:

50242-0214-55, 50242-0227-55, 50242-0227-01, 50242-0215-55, 50242-0040-62, 50242-0215-01, 50242-0214-01

Primary Type:

Anti-Eosinophil Asthma

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Xolair CPT Codes:

Potential CPT administration codes for Xolair can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Xolair:

XOLAIR is an Anti-Eosinophil Asthma drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J2357 is aligned to the drug XOLAIR.

ACCESS PRICING AND MORE BY REGISTERING

J2357 Added Date:

January 1, 2005

J2357 Effective Date:

January 1, 2005

J2357 Termination Date:

HCPCS Active

Xolair billing and coding information can be found through Genentech at the link below:
Xolair patient assistance information can be found through Genentech at the URL: https://www.xolairhcp.com/allergic-asthma/financial-support/assistance-options.html
XOLAIR prescribing information can be found at the link below:
Information regarding XOLAIR’s side effects can be found at MedlinePlus